Search
for

    Did you mean Parkinson's disease?
    Glossary Parkinson's disease

    progressive neurodegenerative disorder affecting movement control due to dopamine loss

    Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects movement control. It is characterized by symptoms such as tremors, stiffness, slowness of movement, and balance problems, resulting from the loss of dopamine-producing neurons in a region of the brain called the substantia nigra.

    Related Terms

    Sort by

    Research 30 of 956

    1. Parkinson's disease and skin 2021 · 28 citations
    2. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach Acta Neurologica Belgica · 2019 · 12 citations
    3. Is seborrhea a sign of autonomic impairment in Parkinson's disease? Journal of Neural Transmission · 1997 · 46 citations
    4. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease Journal of The American Academy of Dermatology · 2006 · 14 citations
    5. Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease Pharmaceuticals · 2023 · 2 citations
    6. Mesenchymal stem cells and their secretome: a promising approach for Parkinson’s disease treatment The Egyptian Journal of Neurology Psychiatry and Neurosurgery · 2026
    7. Hair loss, old and uninterested nonmotor symptom in Parkinson’s disease during dopaminergic therapy Journal of movement disorders · 2023
    8. Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects Frontiers in Immunology · 2026
    9. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors Clinical, cosmetic and investigational dermatology · 2017 · 47 citations
    10. PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection npj Parkinson s Disease · 2025 · 4 citations
    11. Androgens and Parkinson’s disease: the role in humans and in experiment Problems of Endocrinology · 2022 · 1 citations
    12. Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases Chinese Journal of General Practice · 2011
    13. Hair metal dysregulation in Parkinson’s disease: Implications for diagnosis and gut-brain axis involvement iScience · 2026
    14. Hair glucocorticoid levels in Parkinson’s disease Psychoneuroendocrinology · 2020 · 16 citations
    15. Hair Metal Dysregulation in Parkinson's Disease: Implications for Diagnosis and Gut-Brain Axis Involvement SSRN Electronic Journal · 2025
    16. Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease Movement Disorders · 2011 · 47 citations
    17. Finasteride Attenuates Pathological Gambling in Patients With Parkinson Disease Journal of Clinical Psychopharmacology · 2012 · 35 citations
    18. Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities Physiology News · 2021
    19. Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities Physiology News · 2021
    20. Functional Decline and Psychosocial Changes With Parkinson’s Disease 2019
    21. Role of 5α-reductase inhibitors in Parkinson's disease: Gambling or not? The Journal of Steroid Biochemistry and Molecular Biology · 2026
    22. Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition Middle East Fertility Society Journal · 2023
    23. Manganese Content in Hair of Patients with Parkinson’s Disease: Manganese Deficiency and Susceptibility Towards Parkinson’s Disease Advances in behavioral biology · 1990
    24. Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease Experimental neurology · 2023 · 2 citations
    25. Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease Frontiers in Neuroendocrinology · 2024
    26. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease Neuroscience & Biobehavioral Reviews · 2015 · 34 citations
    27. Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease Pharmaceuticals · 2023 · 17 citations
    28. IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway Medical Principles and Practice · 2024 · 8 citations
    29. Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models Frontiers in Pharmacology · 2022 · 1 citations
    30. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease Experimental Neurology · 2017 · 15 citations